Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Superloaf

Explore full profile

Modern Baker develops breakthrough ‘clean label’ ingredient technologies to improve the nutritional profile of carbohydrate-based ultra-processed foods, for the common good

Oxford, United KingdomFounded 2017Food
Valuation $10–25M Last recorded · 2025
Headcount <100 Current team size
Total funding $0–10M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Superloaf and the history behind them.

About Superloaf

Modern Baker is a food technology company operating on a 'food-as-medicine' principle, focused on re-engineering staple foods to be systemically healthier. The company was founded in Oxford, UK, in 2017 by Melissa Sharp and Leo Campbell. The inspiration for the business came from Melissa Sharp's personal health journey following a cancer diagnosis in 2010, which led her to explore the connection between nutrition and chronic illness. Discovering the positive impact of a whole-food diet during her treatment, she and Campbell decided to build a business centered on making everyday foods healthier.

The firm's primary business involves developing and licensing its proprietary 'clean label' ingredient technologies to food manufacturers. This B2B model allows large-scale food producers to incorporate Modern Baker's health-positive formulations into their existing production lines without significant capital expenditure, functioning similarly to a SaaS model. The company's goal is to improve the nutritional profile of widely consumed ultra-processed foods (UPFs), particularly in the $500 billion global bread and baked goods market. The core of their work is deconstructing the nutritional properties of vegetables and rebuilding them into staple products.

Modern Baker's flagship product and proof-of-concept is SUPERLOAF, a sliced bread developed over five years of scientific research. Launched in 2022, SUPERLOAF is engineered to support metabolic and gut health by slowing glucose absorption, optimizing the gut microbiome, and supporting the immune system. It contains a diverse mix of plant-based ingredients, including barley flour, various seeds, hemp, and seaweed, resulting in a high-fiber profile that is richer than many wholemeal loaves. It is also a source of protein, calcium, copper, manganese, and Omega-3 (ALA). Despite being technically an ultra-processed food (UPF) due to its manufacturing method, the company argues it challenges the negative UPF narrative by focusing on nutrient density over nutrient poverty. The loaf is co-manufactured by Hovis and distributed in major UK retailers such as M&S, Sainsbury's, and Ocado.

The company's research is backed by seven grants from Innovate UK, the UK's innovation agency, and private investment, including a £2.5 million Series A round in July 2025 led by Adjuvo. This funding is intended to scale up production of SUPERLOAF, expand distribution, and further develop its ingredient technology platform for other food categories. Modern Baker has collaborated with several scientific institutions, including Newcastle University and Oxford Brookes University, to validate its food science.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
Oxford, United Kingdom
Employees
96
Open positions
None listed
Dealroom signal
85.8/100
Industry
Health, Food
Sub-industry
Innovative Food
Sector
Food, Sustainable Development Goals, Food as Medicine
Business model
Manufacturing
Client focus
b2c

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jul 2025 $3.3M $13M Adjuvo ↗
GRANTOther financing Sep 2023 $594K — Undisclosed ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Superloaf website traffic

Latest recorded traffic for Superloaf is 1.4K monthly website visits, up 0% over the last three months. Superloaf's team grew 24.7% over the past year.

Latest monthly visits1.4K 3-month web change0% 1-year team growth+24.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Adjuvo
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom90%
🇰🇪 Kenya10%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Superloaf on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Superloaf’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.